These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18034994)

  • 1. Activation of the calcineurin/NFAT signalling cascade starts early in human hypertrophic myocardium.
    Diedrichs H; Hagemeister J; Chi M; Boelck B; Müller-Ehmsen J; Schneider CA
    J Int Med Res; 2007; 35(6):803-18. PubMed ID: 18034994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
    Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
    Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndecan-4 is essential for development of concentric myocardial hypertrophy via stretch-induced activation of the calcineurin-NFAT pathway.
    Finsen AV; Lunde IG; Sjaastad I; Østli EK; Lyngra M; Jarstadmarken HO; Hasic A; Nygård S; Wilcox-Adelman SA; Goetinck PF; Lyberg T; Skrbic B; Florholmen G; Tønnessen T; Louch WE; Djurovic S; Carlson CR; Christensen G
    PLoS One; 2011; 6(12):e28302. PubMed ID: 22164265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure.
    Diedrichs H; Chi M; Boelck B; Mehlhorn U; Schwinger RH
    Eur J Heart Fail; 2004 Jan; 6(1):3-9. PubMed ID: 15012912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene, TGR(mREN2)27.
    Diedrichs H; Mei C; Frank KF; Boelck B; Schwinger RH
    J Mol Med (Berl); 2004 Oct; 82(10):688-95. PubMed ID: 15322704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
    Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
    Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
    Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin-induced cardiomyocyte hypertrophy reveals both calcium-dependent and calcium-independent/RhoA-dependent calcineurin activation and NFAT nuclear translocation.
    Rajapurohitam V; Izaddoustdar F; Martinez-Abundis E; Karmazyn M
    Cell Signal; 2012 Dec; 24(12):2283-90. PubMed ID: 22917533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signaling pathway in H9c2 myocardiac cells.
    Liu CJ; Cheng YC; Lee KW; Hsu HH; Chu CH; Tsai FJ; Tsai CH; Chu CY; Liu JY; Kuo WW; Huang CY
    Mol Cell Biochem; 2008 Jun; 313(1-2):167-78. PubMed ID: 18398669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes.
    Fiedler B; Wollert KC
    Cardiovasc Res; 2004 Aug; 63(3):450-7. PubMed ID: 15276470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II and norepinephrine activate specific calcineurin-dependent NFAT transcription factor isoforms in cardiomyocytes.
    Lunde IG; Kvaløy H; Austbø B; Christensen G; Carlson CR
    J Appl Physiol (1985); 2011 Nov; 111(5):1278-89. PubMed ID: 21474694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice.
    Oliveira RS; Ferreira JC; Gomes ER; Paixão NA; Rolim NP; Medeiros A; Guatimosim S; Brum PC
    J Physiol; 2009 Aug; 587(Pt 15):3899-910. PubMed ID: 19505981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.
    Grebe C; Klingebiel TM; Grau SP; Toischer K; Didié M; Jacobshagen C; Dullin C; Hasenfuss G; Seidler T
    Cardiovasc Res; 2011 Jun; 90(3):521-8. PubMed ID: 21273244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Betulinic Acid Protects DOX-Triggered Cardiomyocyte Hypertrophy Response through the GATA-4/Calcineurin/NFAT Pathway.
    Yoon JJ; Son CO; Kim HY; Han BH; Lee YJ; Lee HS; Kang DG
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33374365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy.
    Lunde IG; Aronsen JM; Melleby AO; Strand ME; Skogestad J; Bendiksen BA; Ahmed MS; Sjaastad I; Attramadal H; Carlson CR; Christensen G
    Mol Biol Rep; 2022 Dec; 49(12):11795-11809. PubMed ID: 36205855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ca2+-dependent calcineurin/NFAT signaling in β-adrenergic-induced cardiac hypertrophy.
    Khalilimeybodi A; Daneshmehr A; Sharif Kashani B
    Gen Physiol Biophys; 2018 Jan; 37(1):41-56. PubMed ID: 29424351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling.
    Kuwahara K; Wang Y; McAnally J; Richardson JA; Bassel-Duby R; Hill JA; Olson EN
    J Clin Invest; 2006 Dec; 116(12):3114-26. PubMed ID: 17099778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosage-dependent transcriptional regulation by the calcineurin/NFAT signaling in developing myocardium transition.
    Yang XY; Yang TT; Schubert W; Factor SM; Chow CW
    Dev Biol; 2007 Mar; 303(2):825-37. PubMed ID: 17198697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginseng inhibits cardiomyocyte hypertrophy and heart failure via NHE-1 inhibition and attenuation of calcineurin activation.
    Guo J; Gan XT; Haist JV; Rajapurohitam V; Zeidan A; Faruq NS; Karmazyn M
    Circ Heart Fail; 2011 Jan; 4(1):79-88. PubMed ID: 20971938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.
    Molkentin JD; Lu JR; Antos CL; Markham B; Richardson J; Robbins J; Grant SR; Olson EN
    Cell; 1998 Apr; 93(2):215-28. PubMed ID: 9568714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.